STOCK TITAN

Zomedica to Host Fourth Quarter and Fiscal Year 2022 Financial Results Call on March 15

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Zomedica Corp. (NYSE American:ZOM) will host a conference call on March 15, 2023, at 4:30 p.m. ET to discuss operational and financial highlights for the fourth quarter and fiscal year ended December 31, 2022. Interested parties can join the live call at +1-877-407-0789 (U.S. Toll-Free) or via webcast. A replay of the call will be available until March 29, 2023. Zomedica focuses on creating innovative diagnostic and therapeutic products for companion animals, aiming to enhance veterinary practices.

Positive
  • Upcoming conference call scheduled for March 15, 2023, indicates proactive communication with investors.
  • Focus on innovative diagnostic and therapeutic products for companion animals suggests potential growth in the veterinary health sector.
Negative
  • None.

ANN ARBOR, MI / ACCESSWIRE / March 8, 2023 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering diagnostic and therapeutic products for companion animals, will host a conference call and audio-only webcast on Wednesday, March 15, at 4:30 p.m. ET to discuss the Company's operational and financial highlights for its fourth quarter and fiscal year ended December 31, 2022. A question-and-answer session will follow management's prepared remarks.

Event:Zomedica Q4 and Fiscal Year 2022 Financial Results Conference Call
Date:Wednesday, March 15, 2023
Time:4:30 p.m. Eastern Time
Live Call:+1-877-407-0789 (U.S. Toll-Free) or +1-201-689-8562 (International)
Webcast:https://viavid.webcasts.com/starthere.jsp?ei=1601606&tp_key=1c4e47625b

For interested individuals unable to join the conference call, a dial-in replay of the call will be available until March 29, 2023 and can be accessed by dialing +1-844-512-2921 (U.S. Toll Free) or +1-412-317-6671 (International) and entering replay pin number: 13736703.

About Zomedica

Based in Ann Arbor, Michigan, Zomedica (NYSE American: ZOM) is a veterinary health company creating products for companion animals by focusing on the unmet needs of clinical veterinarians. Zomedica's product portfolio will include innovative diagnostics and medical devices that emphasize patient health and practice health. It is Zomedica's mission to provide veterinarians the opportunity to increase productivity and grow revenue while better serving the animals in their care. For more information, visit www.ZOMEDICA.com.

Follow Zomedica

Email Alerts: http://investors.zomedica.com

LinkedIn: https://www.linkedin.com/company/zomedica

Facebook: https://m.facebook.com/zomedica

Twitter: https://twitter.com/zomedica

Instagram: https://www.instagram.com/zomedica_inc

Investor Relations Contact:

RedChip Companies Inc.
Barrett Boone
barrett@redchip.com
407-571-0912

SOURCE: Zomedica Corp.



View source version on accesswire.com:
https://www.accesswire.com/742587/Zomedica-to-Host-Fourth-Quarter-and-Fiscal-Year-2022-Financial-Results-Call-on-March-15

FAQ

When will Zomedica release its Q4 and fiscal year 2022 financial results?

Zomedica will host a conference call on March 15, 2023, at 4:30 p.m. ET to discuss its Q4 and fiscal year 2022 financial results.

How can I listen to Zomedica's financial results conference call?

You can join the call by dialing +1-877-407-0789 (U.S. Toll-Free) or +1-201-689-8562 (International), or you can access the call via the webcast.

Is there a replay available for Zomedica's conference call?

Yes, a replay of the conference call will be available until March 29, 2023, by dialing +1-844-512-2921 (U.S. Toll-Free) or +1-412-317-6671 (International) and entering the replay pin number: 13736703.

What products does Zomedica focus on?

Zomedica focuses on creating innovative diagnostic and therapeutic products for companion animals, aiming to meet the unmet needs of clinical veterinarians.

Zomedica Corp.

NYSE:ZOM

ZOM Rankings

ZOM Latest News

ZOM Stock Data

118.48M
961.51M
1.78%
8.33%
5.12%
Medical Devices
Pharmaceutical Preparations
Link
United States of America
ANN ARBOR